0
0
6/8/22 at 7:33am
Organization
MarketWatch
Author
Ciara Linnane
40 words
0
Comments
BA.4 and BA.5 subvariants accounted for 13% of cases in the latest week, up from 1% at start of May
You are the first to view
https://www.marketwatch.com/story/new-omicron-subvariants-are-rising-in-u-s-and-fda-panel-gives-its-backing-to-novavax-vaccine-11654698782
Create an account
or login to join the discussion